FDA Press Releases Archives - Page 770 of 815

PMI Nutrition International Initiates Voluntary Recall of AquaMax Products; Expands Voluntary Recall of Mazuri and LabDiet Feed Products Due to Potential Elevated Vitamin D Level

July 15, 2012 By The FDA Leave a Comment

ContactMediaTrish Scorpio, PMI Nutrition International,651-375-1814Consumer1-855-863-0421, x 224 FOR IMMEDIATE RELEASE -July 13, 2012 – PMI Nutrition International is initiating a voluntary recall of certain varieties of the AquaMax™ feed products with specific lot codes listed below, due to the potential for elevated vitamin D … [Read more...]

Voluntary Recall of Feed Solutions Feed Products Due to Potential Elevated Vitamin D Level

July 15, 2012 By The FDA Leave a Comment

ContactMediaTrish Scorpio, Feed Solutions,651-375-1814Consumer1-800-227-8941 FOR IMMEDIATE RELEASE - July 13, 2012 – Feed Solutions has initiated a voluntary recall of certain varieties of the feed products with specific lot codes listed below, due to the potential for elevated vitamin D levels. Elevated vitamin D levels may cause death … [Read more...]

Voluntary Recall of Purina Products Due to Potential Elevated Vitamin D Level

July 14, 2012 By The FDA Leave a Comment

Contact:MediaTrish Scorpio, Land O’Lakes Purina Feed 651-375-1814Consumer (1-800-522-3354) FOR IMMEDIATE RELEASE - July 13, 2012 –Land O’Lakes Purina Feed LLC has initiated a voluntary recall of specific lots of Purina® feed products listed below, due to the potential for elevated vitamin D levels. Elevated vitamin … [Read more...]

Westone Laboratories Inc. Issues Voluntary Nationwide Recall of all sizes and packaging configurations of Oto-Ease ear lubricant due to possible microbial contamination.

July 14, 2012 By The FDA Leave a Comment

ContactConsumer1-800-357-3240 FOR IMMEDIATE RELEASE - July 13,2012, Westone Laboratories, Inc. is initiating a voluntary nationwide recall of all sizes and packaging configurations of Oto-Ease® ear lubricant. The products have been found through a consumer complaint and the U.S. Food and Drug Administration (FDA) sample analysis to … [Read more...]

Hospira Announces A Nationwide Recall of Certain Lots of Injectable Carboplatin, Cytarabine, Paclitaxel and Methotrexate Due to Glass Vial Defect

July 13, 2012 By The FDA Leave a Comment

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, issued this press release today to further inform the general public about a previously communicated user level recall of a total of 19 lots of carboplatin, cytarabine, paclitaxel, and methotrexate (see table below) in the United States due to … [Read more...]